Honghui Huang

775 total citations
37 papers, 471 citations indexed

About

Honghui Huang is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Honghui Huang has authored 37 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 15 papers in Molecular Biology and 13 papers in Hematology. Recurrent topics in Honghui Huang's work include Multiple Myeloma Research and Treatments (10 papers), Lymphoma Diagnosis and Treatment (9 papers) and Viral-associated cancers and disorders (6 papers). Honghui Huang is often cited by papers focused on Multiple Myeloma Research and Treatments (10 papers), Lymphoma Diagnosis and Treatment (9 papers) and Viral-associated cancers and disorders (6 papers). Honghui Huang collaborates with scholars based in China, United States and Hong Kong. Honghui Huang's co-authors include Fangyuan Chen, Minyue Zhang, Lan Xu, Fei Xiao, Yumei Chen, Hua Zhong, Qiang Liu, Ji-Na Zheng, Gang Huang and Jianjun Liu and has published in prestigious journals such as Blood, Cancer and Oncogene.

In The Last Decade

Honghui Huang

37 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Honghui Huang China 14 183 137 123 114 79 37 471
Hua‐Jie Dong China 11 203 1.1× 139 1.0× 129 1.0× 129 1.1× 86 1.1× 21 475
Luigia Monitillo Italy 8 134 0.7× 82 0.6× 121 1.0× 145 1.3× 106 1.3× 16 497
Christoph Heining Germany 9 240 1.3× 118 0.9× 246 2.0× 103 0.9× 71 0.9× 29 567
Hong Cen China 8 91 0.5× 45 0.3× 128 1.0× 119 1.0× 26 0.3× 16 348
Vito Longo Italy 12 127 0.7× 94 0.7× 284 2.3× 54 0.5× 77 1.0× 29 487
Imane El Dika United States 13 207 1.1× 145 1.1× 214 1.7× 86 0.8× 69 0.9× 30 573
Chiara Spoto Italy 10 131 0.7× 123 0.9× 279 2.3× 40 0.4× 74 0.9× 13 584
C. I. Amos United States 6 90 0.5× 47 0.3× 49 0.4× 53 0.5× 53 0.7× 7 393
Joshua N. Honeyman United States 10 289 1.6× 182 1.3× 128 1.0× 62 0.5× 54 0.7× 21 615
Matthew Volm United States 10 119 0.7× 140 1.0× 259 2.1× 115 1.0× 34 0.4× 17 492

Countries citing papers authored by Honghui Huang

Since Specialization
Citations

This map shows the geographic impact of Honghui Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Honghui Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Honghui Huang more than expected).

Fields of papers citing papers by Honghui Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Honghui Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Honghui Huang. The network helps show where Honghui Huang may publish in the future.

Co-authorship network of co-authors of Honghui Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Honghui Huang. A scholar is included among the top collaborators of Honghui Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Honghui Huang. Honghui Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Jia, Yaoxin Zhang, Changming Shih, et al.. (2025). Enhancer Extrachromosomal Circular DNA ANKRD28 Elicits Drug Resistance via POU2F2‐Mediated Transcriptional Network in Multiple Myeloma. Advanced Science. 12(21). e2415695–e2415695. 3 indexed citations
2.
3.
Xiao, Fei, Zebing Liu, Yanying Shen, et al.. (2024). Long-Term Remission with Novel Combined Immune-Targeted Treatment for Histiocytic Sarcoma Accompanied by Follicular Lymphoma: Case Report and Literature Review. International Journal of Molecular Sciences. 25(13). 7293–7293. 1 indexed citations
4.
Huang, Gan, Honghui Huang, Ting Wang, et al.. (2023). Machine Learning Model Based on Optimized Radiomics Feature from 18F-FDG-PET/CT and Clinical Characteristics Predicts Prognosis of Multiple Myeloma: A Preliminary Study. Journal of Clinical Medicine. 12(6). 2280–2280. 13 indexed citations
5.
Peng, Ziyi, Mengping Chen, Honghui Huang, et al.. (2023). C-reactive protein impairs immune response of CD8+ T cells via FcγRIIb-p38MAPK-ROS axis in multiple myeloma. Journal for ImmunoTherapy of Cancer. 11(10). e007593–e007593. 16 indexed citations
6.
7.
Xiang, Jing, Mengping Chen, Xiaofeng Han, et al.. (2023). Distinct mechanisms of dysfunctional antigen‐presenting DCs and monocytes by single‐cell sequencing in multiple myeloma. Cancer Science. 114(7). 2750–2760. 13 indexed citations
8.
Zhang, Minyue, Fei Xiao, Meisi Lin, et al.. (2022). The epidemiology and prognosis of patients with primary gastric T‐cell lymphoma in the SEER program. Cancer Medicine. 12(1). 84–98. 2 indexed citations
9.
Ye, Fen, et al.. (2022). Diffuse Large B-Cell Lymphoma Promotes Endothelial-to-Mesenchymal Transition via WNT10A/Beta-Catenin/Snail Signaling. Frontiers in Oncology. 12. 871788–871788. 7 indexed citations
10.
11.
Zhang, Minyue, Fei Gao, Ling Peng, et al.. (2021). Distinct clinical features and prognostic factors of hepatitis C virus-associated non-Hodgkin’s lymphoma: a systematic review and meta-analysis. Cancer Cell International. 21(1). 524–524. 9 indexed citations
12.
Zhou, Yubo, Yangming Zhang, Honghui Huang, et al.. (2021). Pharmacodynamic, pharmacokinetic, and phase 1a study of bisthianostat, a novel histone deacetylase inhibitor, for the treatment of relapsed or refractory multiple myeloma. Acta Pharmacologica Sinica. 43(4). 1091–1099. 9 indexed citations
13.
Ying, Liang, Lei Tian, Yuanyuan Xie, et al.. (2018). A case of ureteral myeloid sarcoma post-renal transplantation. BMC Nephrology. 19(1). 4 indexed citations
14.
Wang, Sumei, Yunbao Pan, Tong Xu, et al.. (2016). Hsa-miR-24-3p increases nasopharyngeal carcinoma radiosensitivity by targeting both the 3′UTR and 5′UTR of Jab1/CSN5. Oncogene. 35(47). 6096–6108. 70 indexed citations
15.
Huang, Honghui, Fei Xiao, Hua Zhong, et al.. (2016). Correlation of pretreatment 18F-FDG uptake with clinicopathological factors and prognosis in patients with newly diagnosed diffuse large B-cell lymphoma. Nuclear Medicine Communications. 37(7). 689–698. 14 indexed citations
16.
Zhu, Jianyi, Fangyuan Chen, Fei Xiao, et al.. (2014). SLC29A1 single nucleotide polymorphisms as independent prognostic predictors for survival of patients with acute myeloid leukemia: an in vitro study. Journal of Experimental & Clinical Cancer Research. 33(1). 90–90. 22 indexed citations
17.
18.
19.
Huang, Honghui, Fei Xiao, Fangyuan Chen, et al.. (2012). Reassessment of the prognostic value of the International Prognostic Index and the revised International Prognostic Index in patients with diffuse large B-cell lymphoma: A multicentre study. Experimental and Therapeutic Medicine. 4(3). 475–480. 14 indexed citations
20.
Zhong, Hua, et al.. (2009). Modification of TGF-β1 signaling pathway during NB4 cells differentiation by all-trans retinoid acid induction. International Journal of Hematology. 89(4). 438–444. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hua‐Jie Dong Breakdown of academic impact, for papers by Luigia Monitillo Breakdown of academic impact, for papers by Christoph Heining Breakdown of academic impact, for papers by Hong Cen Breakdown of academic impact, for papers by Vito Longo Breakdown of academic impact, for papers by Imane El Dika Breakdown of academic impact, for papers by Chiara Spoto Breakdown of academic impact, for papers by C. I. Amos Breakdown of academic impact, for papers by Joshua N. Honeyman Breakdown of academic impact, for papers by Matthew Volm
Rankless by CCL
2026